Skip to content

Study on OsseoSpeed™ Implants in Patients Missing 2-5 Teeth in the Posterior Lower Jaw, Restored With Permanent Teeth Attached 6-7 Weeks Later

An Open, Prospective Study to Evaluate Implant Stability, Marginal Bone Adaptation and the Survival Rate of Astra Tech Dental Implant System, Fixture Osseospeed™, in Patients With Tooth Loss in the Posterior Mandible in an Early Loading Protocol.

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00711425
Enrollment
45
Registered
2008-07-08
Start date
2004-02-29
Completion date
Unknown
Last updated
2013-09-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Jaw, Edentulous, Partially

Keywords

Jaw, Edentulous, Partially (posterior mandible)

Brief summary

The purpose of the study is to evaluate Astra Tech Dental Implant System, Fixture Osseospeed™, in patients with tooth loss in the posterior mandible in an early loading protocol. Primary objectives are implant stability, marginal bone adaptation and survival rate.

Interventions

OsseoSpeed™, all dimensions

Sponsors

Dentsply Sirona Implants and Consumables
Lead SponsorINDUSTRY

Study design

Allocation
NON_RANDOMIZED
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Provision of written informed consent * 18 years of age and over * Edentulous in the posterior mandible, Kennedy class I or class II. Last natural tooth, or previously restored implant in function is canine or first bicuspid. * Deemed by the investigator as likely to present an initially stabile implant situation suitable for early loading

Exclusion criteria

* Untreated caries and/or periodontal disease of residual dentition * History of edentulism in the area of implant placement of less than two months * Current need for pre-surgical bone or soft tissue augmentation in the planned implant area. * History of pre-surgical bone or soft tissue augmentation, within12 months, in the planned implant area. * Any systemic or local disease or condition that would compromise post-operative healing and/or osseointegration * Need for systemic corticosteroids or any other medication that would compromise post-operative healing and/or osseointegration * Present alcohol or drug abuse * Unable or unwilling to return for follow-up visits for a period of 5 years * Current use of smoking tobacco * Pregnancy or lactation at the time of enrollment

Design outcomes

Primary

MeasureTime frameDescription
Implant Survival RateAt 5 year follow-upAn implant that has failed to osseointegrate, lost its osseointegration or fractured will be considered a failure effective from the date of removal. The survival rate for individual implants will be analyzed at each visit. Cumulative implant survival rate will be calculated using Kaplan-Meier life-table estimation and reported as percentage of survived implants.
Implant StabilityAt 1 year follow-upImplant stability will be evaluated using Resonance Frequency Analysis (RFA). The RFA value is automatically translated into an Implant Stability Quotient index (ISQ), which runs from 1 to 100.
Marginal Bone AdaptationAt 5 year follow-upMarginal bone adaptation will be expressed as the distance from the implant reference point to the most coronal bone-to-implant contact on the mesial and distal side of the implant. Bone adaptation in millimeters at follow-up visit will be compared to values obtained Baseline (loading). Positive value indicates bone gain and negative value bone loss.

Countries

Germany, United States

Participant flow

Participants by arm

ArmCount
OsseoSpeed
Fixture Osseospeed Implants with diameter of 3.5, 4.0, 4.5 and 5.0 mm and lengths of 8, 9, 11, 13, 15 and 17 mm.
44
Total44

Withdrawals & dropouts

PeriodReasonFG000
Overall StudyDeath2
Overall StudyLost to Follow-up1
Overall StudyProtocol Violation1

Baseline characteristics

CharacteristicOsseoSpeed
Age Continuous57 years
STANDARD_DEVIATION 10
Region of Enrollment
Germany
15 participants
Region of Enrollment
United States
29 participants
Sex: Female, Male
Female
22 Participants
Sex: Female, Male
Male
22 Participants

Adverse events

Event typeEG000
affected / at risk
deaths
Total, all-cause mortality
— / —
other
Total, other adverse events
0 / 45
serious
Total, serious adverse events
17 / 45

Outcome results

Primary

Implant Stability

Implant stability will be evaluated using Resonance Frequency Analysis (RFA). The RFA value is automatically translated into an Implant Stability Quotient index (ISQ), which runs from 1 to 100.

Time frame: At 1 year follow-up

Population: Per protocol analysis presented, this includes implants loaded 0 to 56 days from implant placement (134 implants in 44 patients).At 1-year follow-up, 43 patients were still in the study and thus evaluable for the analysis.

ArmMeasureValue (MEAN)Dispersion
OsseoSpeedImplant Stability77.4 ISQStandard Deviation 7.1
Primary

Implant Survival Rate

An implant that has failed to osseointegrate, lost its osseointegration or fractured will be considered a failure effective from the date of removal. The survival rate for individual implants will be analyzed at each visit. Cumulative implant survival rate will be calculated using Kaplan-Meier life-table estimation and reported as percentage of survived implants.

Time frame: At 5 year follow-up

Population: Per protocol analysis presented, this includes implants loaded 0 to 56 days from implant placement (134 implants in 44 patients).

ArmMeasureValue (NUMBER)
OsseoSpeedImplant Survival Rate100 Percentage of implants
Primary

Marginal Bone Adaptation

Marginal bone adaptation will be expressed as the distance from the implant reference point to the most coronal bone-to-implant contact on the mesial and distal side of the implant. Bone adaptation in millimeters at follow-up visit will be compared to values obtained Baseline (loading). Positive value indicates bone gain and negative value bone loss.

Time frame: At 5 year follow-up

Population: Per protocol analysis presented, this includes implants loaded 0 to 56 days from implant placement (134 implants in 44 patients). At 5-year follow-up, 41 patients were still in the study and thus evaluable for the analysis.

ArmMeasureValue (MEAN)Dispersion
OsseoSpeedMarginal Bone Adaptation-0.05 MillimeterStandard Deviation 1.96

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026